-
1
المؤلفون: Kim Linton, Sridhar Chaganti, Kate Cwynarski, Josh Wright, Dominic Culligan, Roderick J. Johnson, Stefanie Thust, Ayesha S. Ali, Louise Hopkins, Aimee Jackson, Jeffery Smith, Andrew Davies, Andrés J.M. Ferreri, Shireen Kassam, Christopher P. Fox, Catherine Thomas, Ian Chau, David J. Lewis, Graham P. Collins, Nicolas Martinez-Calle, Dorothee P. Auer, Graham McIlroy
المصدر: Fox, C P, Ali, A S, McIlroy, G, Thust, S, Martinez-Calle, N, Jackson, A E, Hopkins, L M, Thomas, C M, Kassam, S, Wright, J, Chaganti, S, Smith, J, Chau, I, Culligan, D, Linton, K M, Collins, G P, Ferreri, A J M, Lewis, D, Davies, A J, Johnson, R, Auer, D P & Cwynarski, K 2021, ' A phase 1/2 study of thiotepa-based immunochemotherapy in relapsed/refractory primary CNS lymphoma : the TIER trial ', Blood Advances, vol. 5, no. 20, pp. 4073-4082 . https://doi.org/10.1182/bloodadvances.2021004779
مصطلحات موضوعية: Oncology, medicine.medical_specialty, medicine.medical_treatment, ThioTEPA, Neutropenia, Transplantation, Autologous, Lymphoma, Non-Hodgkin/drug therapy, Autologous stem-cell transplantation, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Prospective Studies, Chemotherapy, Ifosfamide, Manchester Cancer Research Centre, business.industry, Lymphoma, Non-Hodgkin, Antineoplastic Combined Chemotherapy Protocols/adverse effects, ResearchInstitutes_Networks_Beacons/mcrc, Hematopoietic Stem Cell Transplantation, Primary central nervous system lymphoma, Hematology, Thiotepa/therapeutic use, medicine.disease, Combined Modality Therapy, Regimen, Rituximab, business, Thiotepa, medicine.drug
وصف الملف: text
-
2كتاب
المؤلفون: Bührig, Johann K.
المساهمون: Universität Zürich
Degree: doctoral -- Universität Zürich -- 1970.